Asthma
COPD
Pulmonary
Search
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
Type: Article
COPD
Trial begins for potential COPD treatment
Enrollment is underway in the phase 2b CARDINAL trial for vapendavir in COPD patients with rhinovirus.
May 7, 2026
COPD
Collaboration looks to leverage technology for respiratory diagnoses, treatments
Researchers to explore the potential for proprietary flow cytometry and AI diagnostic tests targeting COPD and asthma.
May 7, 2026
Asthma
Double whammy: Chronic rhinosinusitis, allergic rhinitis linked to increased asthma risk
Clinicians are urged to increase vigilance in cases involving both conditions.
May 6, 2026
Asthma
Severe asthma linked to nearly double mortality risk
Nordic researchers suggest improved management and targeted treatment strategies.
May 6, 2026
Pulmonary
Exploration of lung scarring reversal
An experimental drug targeting ID1 and ID3 could both halt and undo damage caused by pulmonary fibrosis.
May 5, 2026
Pulmonary
Lung scan differences help signal sarcoidosis severity
Analytic findings could lead to improved classification, disease prediction and personalized care plans.
May 1, 2026
Asthma
Benralizumab drives clinical remission in severe eosinophilic asthma
Study supports the growing role of targeted biologic therapies over inhaled and oral corticosteroids.
April 30, 2026
Asthma
FDA approves AstraZeneca’s Breztri for asthma
Based on results from phase 3 KALOS and LOGOS trials, the approval expands the therapy’s use beyond COPD.
April 30, 2026
COPD
Legumes, soy products may help improve COPD symptoms
Isoflavones in these foods may reduce inflammation in patients with COPD.
April 29, 2026
Pulmonary
A new target to alleviate PAH
Japanese scientists demonstrated the role of CNP/GC-B signaling and suggest supplemental therapy to prevent or slow disease progression.
April 29, 2026
COPD
Losing sleep over COPD
Study finds poor sleep quality is more than a symptom but a prognostic marker in patients with COPD.
April 29, 2026
Pulmonary
Hiding in plain sight
Research reveals how rare lung cancers with mixed tumor features can progress and transform.
April 23, 2026
Pulmonary
Human airway models could pave way for improved devices, therapies
A computational study illustrates the need for patient-specific modeling to treat certain pulmonary conditions.
April 23, 2026
COPD
Tozorakimab scores again at reducing COPD exacerbations
The IL-33-targeting biologic has completed three positive phase 3 trials in 2026.
April 23, 2026
COPD
HIV raises risk for COPD, emphysema
A previously unknown mechanism disrupts the lungs’ internal ‘clock,’ leading to inflammation and airway damage.
April 23, 2026
Asthma
Deep learning-assisted phenotyping of complex respiratory diseases
Novel approach shows promise for identifying asthma–COPD overlap.
April 21, 2026
Asthma
Unique approach to restoring immune regulation
Researchers pinpoint unseen mechanism driving immune dysfunction in allergic asthma and propose targeted reversal therapy.
April 21, 2026
Pulmonary
Inhaled treprostinil reduces FVC decline
Trial meets primary and secondary endpoints in the treatment of idiopathic pulmonary fibrosis in adults.
April 17, 2026
Previous Page
Next Page